$SESN If the confirmatory trial primary endpoint is going to try to demonstrate Vicinium's superiority to BCG, it's going to fail. I hope they are not considering this. Complete response rate for BCG at 12 month is greater than 70%. That's why it's the standard first line med.
  • 3